Early-stage potential Very small team with minimal reported revenue suggests early development stage and potential for collaboration on discovery or preclinical projects. Focus sales efforts on partnering, sponsored research, or technology licensing to accelerate pipeline.

Specialized biotech target Operates in biotechnology research with a fixed address in San Diego, a hub for biotech innovation. Position offerings around high-value research tools, assay development, or contract research services that align with a lean, focused R&D setup.

Limited funding signals Revenue under one million indicates tight budgets. Propose cost-effective, modular solutions or pilot programs with flexible pricing and scalable terms to fit cash flow constraints and lower risk for the company.

Strategic collaborations The small headcount implies reliance on external partnerships. Highlight co-development, grant-supported projects, and CRO/CMO partnerships as avenues to extend capabilities without significant internal hires.

Long-term scalability While current scale is tiny, proximity to major pharma ecosystems (San Diego biotech cluster) offers opportunities to connect with larger players for potential acquisition, licensing, or joint ventures as the company matures.